Skip to main content
Medical Data Vision Co.,Ltd. logo

Medical Data Vision Co.,Ltd. — Investor Relations & Filings

Ticker · 3902 ISIN · JP3921250001 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 74 across all filing types
Latest filing 2022-03-29 Governance Information
Country JP Japan
Listing T 3902

About Medical Data Vision Co.,Ltd.

https://en.mdv.co.jp/

Medical Data Vision Co., Ltd. (MDV) is a healthcare data provider that operates one of the largest medical databases in its market. The company aggregates and processes real-world administrative data from hundreds of hospitals, encompassing records for over 50 million patients. This database provides detailed insights into treatment patterns, patient conditions, and medication decision-making. MDV offers data and analytical services primarily to pharmaceutical companies, medical device manufacturers, and research institutions for use in research, development, and market analysis. Additionally, the company provides information and communication technology (ICT) solutions and management support systems for medical institutions.

Recent filings

Filing Released Lang Actions
内部統制報告書-第19期(令和3年1月1日-令和3年12月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. This type of report details the framework, scope, and effectiveness of a company's internal controls over financial reporting. It is a standalone regulatory filing required by Japanese law, distinct from a full Annual Report (10-K) or a simple announcement. Since it is a specific regulatory disclosure document regarding internal control systems, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback for this type of specialized compliance document.
2022-03-29 Japanese
有価証券報告書-第19期(令和3年1月1日-令和3年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2021. It is a full annual report, not an announcement or a summary. FY 2021
2022-03-29 Japanese
四半期報告書-第19期第3四半期(令和3年7月1日-令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the third quarter of the fiscal year 2021. It also includes management analysis and notes to the financial statements. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. 9M 2021
2021-11-09 Japanese
四半期報告書-第19期第2四半期(令和3年4月1日-令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, covering the second quarter of the 19th fiscal period (April 1, 2021, to June 30, 2021). It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR). Q2 2021
2021-08-11 Japanese
四半期報告書-第19期第1四半期(令和3年1月1日-令和3年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Medical Data Vision Co., Ltd. covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial statements, including the balance sheet, income statement, and notes to the financial statements, as required by the Financial Instruments and Exchange Act of Japan. Since it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). Q1 2021
2021-05-13 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2020
2021-03-23 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.